Submitted by Anonymous (not verified) on 11 September 2026 - 15:11
Human medicines European public assessment report (EPAR): Bilprevda, denosumab, Date of authorisation: 17/09/2025, Revision: 5, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Bilprevda, denosumab, Date of authorisation: 17/09/2025, Revision: 5, Status: Authorised